(Q43425324)

English

Protective immunity against Toxoplasma challenge in mice by coadministration of T. gondii antigens and Eimeria profilin-like protein as an adjuvant

scientific article published on 31 January 2009

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

Protective immunity against Toxoplasma challenge in mice by coadministration of T. gondii antigens and Eimeria profilin-like protein as an adjuvant (English)

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

Toxoplasma gondii

0 references

author name string

Dorsaf Hedhli

1

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

Isabelle Dimier-Poisson

2

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

John W Judge

3

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

Barnett Rosenberg

4

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

Marie Noëlle Mévélec

5

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

language of work or name

0 references

publication date

31 January 2009

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

27

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

16

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

2274-2281

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

Interleukin 12 is required for the T-lymphocyte-independent induction of interferon gamma by an intracellular parasite and induces resistance in T-cell-deficient hosts

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.100

7 January 2021

Rapid recruitment of neutrophils containing prestored IL-12 during microbial infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.100

7 January 2021

In vivo microbial stimulation induces rapid CD40 ligand-independent production of interleukin 12 by dendritic cells and their redistribution to T cell areas

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.100

7 January 2021

Plasmacytoid dendritic cells are activated by Toxoplasma gondii to present antigen and produce cytokines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.100

7 January 2021

Cell-mediated immunity to Toxoplasma gondii: initiation, regulation and effector function

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.100

7 January 2021

Cutting edge: MyD88 is required for resistance to Toxoplasma gondii infection and regulates parasite-induced IL-12 production by dendritic cells.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.100

7 January 2021

Toxoplasma gondii genotype determines MyD88-dependent signaling in infected macrophages

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.100

7 January 2021

Cutting edge: dendritic cells are essential for in vivo IL-12 production and development of resistance against Toxoplasma gondii infection in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.100

7 January 2021

Humoral immune response in IL-12 and IFN-gamma deficient mice after infection with Cryptosporidium parvum

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.100

7 January 2021

Innate immunity--cross-talk with adaptive immunity through pattern recognition receptors and cytokines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.100

7 January 2021

Translating innate immunity into immunological memory: implications for vaccine development

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.100

7 January 2021

Protective effect of vaccination with Toxoplasma lysate antigen and CpG as an adjuvant against Toxoplasma gondii in susceptible C57BL/6 mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.100

7 January 2021

Evaluation of protective effect of recombinant dense granule antigens GRA2 and GRA6 formulated in monophosphoryl lipid A (MPL) adjuvant against Toxoplasma chronic infection in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.100

7 January 2021

Protein from intestinal Eimeria protozoan stimulates IL-12 release from dendritic cells, exhibits antitumor properties in vivo and is correlated with low intestinal tumorigenicity.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.100

7 January 2021

Recombinant Eimeria protozoan protein elicits resistance to acute phlebovirus infection in mice but not hamsters

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.100

7 January 2021

Prophylactic treatment with recombinant Eimeria protein, alone or in combination with an agonist cocktail, protects mice from Banzi virus infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.100

7 January 2021

TLR11 activation of dendritic cells by a protozoan profilin-like protein.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.100

7 January 2021

Improving vaccines by incorporating immunological coadjuvants

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.100

7 January 2021

Mucosal defences against orally acquired protozoan parasites, emphasis on Toxoplasma gondii infections

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.100

7 January 2021

Toxoplasma gondii and mucosal immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.100

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.100

7 January 2021

Molecular and cellular basis of immune protection of mucosal surfaces

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.100

7 January 2021

Intranasal immunization with Toxoplasma gondii SAG1 induces protective cells into both NALT and GALT compartments

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.100

7 January 2021

Intranasal immunization with SAG1 and nontoxic mutant heat-labile enterotoxins protects mice against Toxoplasma gondii

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.100

7 January 2021

The MIC3 gene of Toxoplasma gondii is a novel potent vaccine candidate against toxoplasmosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.100

7 January 2021

Toxoplasma profilin is essential for host cell invasion and TLR11-dependent induction of an interleukin-12 response.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.100

7 January 2021

Interleukin-12 induces interferon-gamma-dependent switching of IgG alloantibody subclass

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.100

7 January 2021

The immunodominant Eimeria acervulina sporozoite antigen previously described as p160/p240 is a 19-kilodalton antigen present in several Eimeria species

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.100

7 January 2021

CpG oligonucleotides as adjuvant in therapeutic vaccines against parasitic infections.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.100

7 January 2021

The Mycoplasma-derived lipopeptide MALP-2 is a potent mucosal adjuvant

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.100

7 January 2021

Synthetic double-stranded RNA poly(I:C) combined with mucosal vaccine protects against influenza virus infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.100

7 January 2021

Monophosphoryl lipid A enhances mucosal and systemic immunity to vaccine antigens following intranasal administration

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.100

7 January 2021

A bacterial flagellin, Vibrio vulnificus FlaB, has a strong mucosal adjuvant activity to induce protective immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.100

7 January 2021

Immunostimulatory DNA is a potent mucosal adjuvant

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.100

7 January 2021

The microbial mimic poly IC induces durable and protective CD4+ T cell immunity together with a dendritic cell targeted vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.100

7 January 2021

The binding affinity of double-stranded RNA motifs to HIV-1 Tat protein affects transactivation and the neutralizing capacity of anti-Tat antibodies elicited after intranasal immunization

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.100

7 January 2021

Endotoxin-tolerant mice have mutations in Toll-like receptor 4 (Tlr4)

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.100

7 January 2021

Immunostimulatory DNA sequences function as T helper-1-promoting adjuvants.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.100

7 January 2021

Immunostimulatory sequence oligodeoxynucleotide: A novel mucosal adjuvant

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.100

7 January 2021

Toll-dependent selection of microbial antigens for presentation by dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.100

7 January 2021

Toll-like receptor recognition regulates immunodominance in an antimicrobial CD4+ T cell response

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.100

7 January 2021

Oral immunization with Toxoplasma gondii antigens in association with cholera toxin induces enhanced protective and cell-mediated immunity in C57BL/6 mice.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.100

7 January 2021

based on heuristic

inferred from DOI database lookup

Intranasal immunization with SAG1 protein of Toxoplasma gondii in association with cholera toxin dramatically reduces development of cerebral cysts after oral infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.100

7 January 2021

based on heuristic

inferred from DOI database lookup

Antibody responses to Toxoplasma gondii in sera, intestinal secretions, and milk from orally infected mice and characterization of target antigens

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.100

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VACCINE.2009.01.100

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43425324&oldid=1988503875"